Overview of generic versions of Platinib

Pralsetinib is a highly effective therapeutic drug for the treatment of specific mutated non-small cell lung cancer (NSCLC) and thyroid cancer, and has been widely used around the world. However, its high price prohibits many patients. Fortunately, some generic versions of platinib have emerged on the market, providing patients with more treatment options.

Currently, generic drugs of platinib such as seputinib are available on the market. These generic drugs are highly similar to the original drug Platinib in terms of ingredients, but there are certain differences in production specifications and prices. Take the Laos Lucius Pharmaceutical Factory (Lucius) as an example. The generic medicine they produce is 100mg*120 tablets, and the price is about more than 4,000 yuan (the price may fluctuate due to exchange rates and other factors). Compared with the original medicine, it is undoubtedly a more people-friendly choice.

Platinib and its generic drugs belong to the category of anti-tumor drugs, which exert therapeutic effects by interfering with the growth mechanism of cancer cells. Before using this type of drug, doctors will perform RET gene fusion testing on patients to ensure the effectiveness and safety of the drug. Platinib and its generic drugs are mainly used to treat patients with metastatic non-small cell lung cancer and thyroid cancer with RET fusion-positive genes, especially those who have received radioactive iodine therapy but with poor results.

The original drug Platinib is already on the market in China, but because it has not been included in the medical insurance catalog, its price is still high. In comparison, the prices of overseas Platinib original drugs and generic drugs are more diverse, but generally show a higher price trend. Therefore, for patients with limited financial conditions, choosing generic drugs may be a more practical option.